Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Fielmann AG (FIE.DE)
EUR39.55
-0.85 (-2.10%)
DE XETRA Healthcare Medical - Instruments & Supplies
Address
Weidestrasse 118a 22083
Hamburg, DE
Hamburg, DE
CEO
Marc Fielmann
Website
fielmann.eu
IPO
2000-10-06
ISIN DE0005772206
Also trades on
Deutsche Börse · FIE.DE (EUR)
Other OTC · FLMNF (USD)
Other OTC · FLMNY (USD)
Description
Through its subsidiaries, Fielmann Aktiengesellschaft focuses on investing in and managing businesses within the optics and hearing aid sectors. It produces and distributes an extensive array of visual aids, such as spectacles, frames, lenses, sunglasses, contact lenses, and related accessories. In addition to these optical offerings, Fielmann provides hearing aids, their accompanying accessories, and diverse general merchandise. By the close of 2021, its retail footprint encompassed 693 stores, predominantly in Germany (610), along with significant operations in Spain (87), Italy (43), Switzerland (45), Austria (38), Poland (37), Slovenia (32), Luxembourg (3), and an additional 15 outlets scattered across other European nations. An additional 78 smaller establishments are maintained throughout Eastern Europe. Its product range is also available for purchase via its digital storefronts. Founded in 1972, the firm's headquarters are situated in Hamburg, Germany. Fielmann Aktiengesellschaft operates as a subsidiary of Korva SE.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
EUR39.55
-0.85 (-2.10%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
57.8K
Beta
0.62
Float Shares
22.74M
Free Float %
27.1%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.08% | -1.90% | -8.83% | -6.77% | -6.35% | -5.06% | -24.64% | -15.65% | -35.47% | -36.09% | +302.93% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
39.55
DCF (Unlevered)
144.11
+264.4%
DCF (Levered)
156.42
+295.5%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
75% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 4 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
3.46
Safe zone
Piotroski F-Score
3 / 9
Average
MOAT Score
6 / 10
Developing
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
3 / 5
Medium
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Instruments & Supplies: +7.9%+7.6% Q1'26: +3.4% (vs Q1'25)
-
EPS growth Medical - Instruments & Supplies: +16.3%+34.3% ★ Q1'26: +6.5% (vs Q1'25)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%+13.4% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Medical - Instruments & Supplies: +13.5%+13.3% Q1'26: +14.8% (vs Q1'25)
-
ROIC Medical - Instruments & Supplies: +6.0%+13.8% ★ Q1'26: +33.1% (vs Q1'25)
-
Share dilution Medical - Instruments & Supplies: +0.1%0.0% Q1'26: +0.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×1.60× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 1996 actual |
Dec 1997 actual |
Dec 1998 actual |
Dec 1999 actual |
Dec 2000 actual |
Dec 2001 actual |
Dec 2002 actual |
Dec 2003 actual |
Dec 2004 actual |
Dec 2005 actual |
Dec 2006 actual |
Dec 2007 actual |
Dec 2008 actual |
Dec 2009 actual |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 8 Rev. Ana. 9 EPS Ana. |
Dec 2027 9 Rev. Ana. 9 EPS Ana. |
Dec 2028 8 Rev. Ana. 6 EPS Ana. |
Dec 2029 7 Rev. Ana. 4 EPS Ana. |
Dec 2030 7 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
455.46M
est.
|
408.38M
est.
|
471.80M
est.
|
506.89M
est.
|
575.52M
est.
|
639.45M
est.
|
658.59M
est: 670.94M (-1.8%)
|
821.70M
est: 818.78M (+0.4%)
|
647.14M
est: 666.88M (-3.0%)
|
733.07M
est: 750.61M (-2.3%)
|
792.91M
est: 808.37M (-1.9%)
|
839.19M
est: 864.51M (-2.9%)
|
902.67M
est: 917.48M (-1.6%)
|
952.50M
est: 963.99M (-1.2%)
|
994.22M
est: 1.02B (-2.5%)
|
1.05B
est: 1.08B (-2.0%)
|
1.11B
est: 1.13B (-1.8%)
|
1.16B
est: 1.18B (-1.9%)
|
1.23B
est: 1.25B (-1.9%)
|
1.30B
est: 1.30B (-0.1%)
|
1.34B
est: 1.33B (+0.2%)
|
1.39B
est: 1.39B (-0.3%)
|
1.43B
est: 1.43B (-0.2%)
|
1.52B
est: 1.52B (+0.1%)
|
1.43B
est: 1.42B (+0.3%)
|
1.68B
est: 1.68B (-0.4%)
|
1.76B
est: 1.76B (+0.0%)
|
1.97B
est: 2.08B (-5.3%)
|
2.26B
est: 2.26B (+0.2%)
|
2.44B
est: 2.45B (-0.6%)
|
2.56B
2.54B – 2.59B
+4.6% YoY
|
2.70B
2.63B – 2.76B
+5.4% YoY
|
2.85B
2.85B – 2.86B
+5.7% YoY
|
3.02B
2.97B – 3.08B
+6.0% YoY
|
3.19B
3.13B – 3.24B
+5.4% YoY
|
| EBITDA |
97.68M
est.
|
45.46M
est.
|
22.53M
est.
|
90.46M
est.
|
104.53M
est.
|
115.23M
est.
|
66.69M
est: 98.31M (-32.2%)
|
70.96M
est: 123.62M (-42.6%)
|
55.74M
est: 126.44M (-55.9%)
|
119.77M
est: 120.28M (-0.4%)
|
315.60M
est: 124.28M (+153.9%)
|
164.76M
est: 150.58M (+9.4%)
|
186.95M
est: 141.57M (+32.1%)
|
197.44M
est: 166.54M (+18.6%)
|
202.48M
est: 168.77M (+20.0%)
|
206.49M
est: 209.55M (-1.5%)
|
217.58M
est: 214.13M (+1.6%)
|
234.45M
est: 222.16M (+5.5%)
|
265.64M
est: 244.56M (+8.6%)
|
280.16M
est: 273.18M (+2.6%)
|
281.26M
est: 280.43M (+0.3%)
|
290.70M
est: 290.76M (0.0%)
|
295.79M
est: 291.40M (+1.5%)
|
385.18M
est: 309.43M (+24.5%)
|
328.70M
est: 338.97M (-3.0%)
|
389.78M
est: 389.52M (+0.1%)
|
346.99M
est: 406.36M (-14.6%)
|
399.17M
est: 444.93M (-10.3%)
|
475.73M
est: 493.80M (-3.7%)
|
553.35M
est: 523.86M (+5.6%)
|
547.94M
543.21M – 554.32M
+4.6% YoY
|
577.62M
561.60M – 591.16M
+5.4% YoY
|
610.48M
609.06M – 611.90M
+5.7% YoY
|
646.91M
634.99M – 658.35M
+6.0% YoY
|
681.73M
669.17M – 693.79M
+5.4% YoY
|
| EBIT |
51.55M
est.
|
46.44M
est.
|
23.34M
est.
|
56.73M
est.
|
69.73M
est.
|
75.05M
est.
|
26.89M
est: 58.23M (-53.8%)
|
27.87M
est: 76.88M (-63.8%)
|
18.73M
est: 92.91M (-79.8%)
|
564.04M
est: 79.97M (+605.3%)
|
278.99M
est: 93.69M (+197.8%)
|
132.75M
est: 114.32M (+16.1%)
|
155.89M
est: 144.65M (+7.8%)
|
165.93M
est: 170.00M (-2.4%)
|
168.62M
est: 172.27M (-2.1%)
|
175.52M
est: 179.24M (-2.1%)
|
182.71M
est: 181.30M (+0.8%)
|
200.62M
est: 188.38M (+6.5%)
|
227.69M
est: 210.32M (+8.3%)
|
241.33M
est: 238.54M (+1.2%)
|
241.76M
est: 245.06M (-1.3%)
|
248.93M
est: 254.08M (-2.0%)
|
251.12M
est: 254.39M (-1.3%)
|
256.70M
est: 266.25M (-3.6%)
|
178.44M
est: 231.27M (-22.8%)
|
214.44M
est: 265.76M (-19.3%)
|
168.59M
est: 277.25M (-39.2%)
|
203.01M
est: 238.71M (-15.0%)
|
260.71M
est: 336.91M (-22.6%)
|
323.54M
est: 281.06M (+15.1%)
|
293.98M
291.44M – 297.40M
+4.6% YoY
|
309.90M
301.31M – 317.17M
+5.4% YoY
|
327.53M
326.77M – 328.29M
+5.7% YoY
|
347.08M
340.68M – 353.22M
+6.0% YoY
|
365.76M
359.02M – 372.23M
+5.4% YoY
|
| Net Income |
28.49M
est.
|
21.70M
est.
|
11.32M
est.
|
31.69M
est.
|
34.92M
est.
|
41.65M
est.
|
44.96M
est: 39.35M (+14.3%)
|
70.14M
est: 52.96M (+32.4%)
|
44.33M
est: 55.98M (-20.8%)
|
55.05M
est: 48.42M (+13.7%)
|
69.06M
est: 59.23M (+16.6%)
|
82.04M
est: 73.90M (+11.0%)
|
110.65M
est: 83.95M (+31.8%)
|
114.35M
est: 116.21M (-1.6%)
|
120.83M
est: 117.78M (+2.6%)
|
121.74M
est: 123.98M (-1.8%)
|
126.37M
est: 127.62M (-1.0%)
|
138.03M
est: 132.21M (+4.4%)
|
157.32M
est: 146.29M (+7.5%)
|
165.53M
est: 166.18M (-0.4%)
|
166.31M
est: 169.25M (-1.7%)
|
167.63M
est: 174.91M (-4.2%)
|
168.89M
est: 171.22M (-1.4%)
|
172.20M
est: 179.33M (-4.0%)
|
116.41M
est: 155.51M (-25.1%)
|
136.86M
est: 178.70M (-23.4%)
|
103.66M
est: 117.53M (-11.8%)
|
127.64M
est: 143.95M (-11.3%)
|
152.11M
est: 152.38M (-0.2%)
|
203.73M
est: 204.89M (-0.6%)
|
221.32M
207.81M – 237.58M
+8.0% YoY
|
247.45M
226.52M – 273.44M
+11.8% YoY
|
280.04M
235.40M – 315.24M
+13.2% YoY
|
278.88M
272.20M – 285.30M
-0.4% YoY
|
297.59M
290.46M – 304.43M
+6.7% YoY
|
| SGA |
52.60M
est.
|
119.34M
est.
|
157.12M
est.
|
158.15M
est.
|
191.78M
est.
|
225.72M
est.
|
—
est: 233.14M (-100.0%)
|
—
est: 284.70M (-100.0%)
|
—
est: 232.93M (-100.0%)
|
—
est: 252.56M (-100.0%)
|
—
est: 300.36M (-100.0%)
|
—
est: 319.02M (-100.0%)
|
—
est: 333.98M (-100.0%)
|
—
est: 361.86M (-100.0%)
|
—
est: 385.46M (-100.0%)
|
—
est: 406.79M (-100.0%)
|
435.68M
est: 433.81M (+0.4%)
|
458.74M
est: 681.86M (-32.7%)
|
484.27M
est: 723.60M (-33.1%)
|
245.20M
est: 754.22M (-67.5%)
|
249.43M
est: 781.95M (-68.1%)
|
257.23M
est: 830.11M (-69.0%)
|
272.86M
est: 843.67M (-67.7%)
|
164.30M
est: 917.61M (-82.1%)
|
158.99M
est: 768.53M (-79.3%)
|
189.25M
est: 883.14M (-78.6%)
|
221.74M
est: 921.31M (-75.9%)
|
225.29M
est: 250.74M (-10.1%)
|
255.76M
est: 1.12B (-77.2%)
|
332.55M
est: 295.22M (+12.6%)
|
308.79M
306.12M – 312.38M
+4.6% YoY
|
325.51M
316.49M – 333.14M
+5.4% YoY
|
344.03M
343.23M – 344.83M
+5.7% YoY
|
364.56M
357.84M – 371.01M
+6.0% YoY
|
384.19M
377.11M – 390.98M
+5.4% YoY
|
| EPS |
0.34
est.
|
0.16
est.
|
0.35
est.
|
0.42
est.
|
0.45
est.
|
0.46
est.
|
0.56
est: 0.55 (+1.9%)
|
0.83
est: 0.77 (+7.5%)
|
0.55
est: 0.58 (-5.7%)
|
0.66
est: 0.67 (-1.3%)
|
0.82
est: 0.83 (-1.0%)
|
0.94
est: 0.95 (-1.5%)
|
1.32
est: 1.34 (-1.8%)
|
1.34
est: 1.32 (+1.4%)
|
1.40
est: 1.47 (-4.6%)
|
1.46
est: 1.59 (-8.5%)
|
1.51
est: 1.53 (-1.3%)
|
1.64
est: 1.63 (+0.4%)
|
1.87
est: 1.87 (+0.2%)
|
1.97
est: 2.01 (-2.0%)
|
1.98
est: 1.94 (+1.9%)
|
2.00
est: 2.01 (-0.7%)
|
2.01
est: 2.04 (-1.2%)
|
2.05
est: 2.06 (-0.7%)
|
1.39
est: 1.33 (+4.6%)
|
1.63
est: 1.66 (-1.9%)
|
1.23
est: 1.25 (-1.5%)
|
1.49
est: 1.71 (-13.1%)
|
1.81
est: 1.82 (-0.3%)
|
2.43
est: 2.43 (+0.2%)
|
2.64
2.48 – 2.83
+8.7% YoY
|
2.95
2.70 – 3.26
+11.9% YoY
|
3.30
2.80 – 3.75
+11.7% YoY
|
3.32
3.24 – 3.40
+0.8% YoY
|
3.54
3.46 – 3.63
+6.7% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-08 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-07 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-05 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-04 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-15 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
140.00M
OE per share TTM
1.67
Owner's Yield
3.99%
Maintenance CapEx ratio
61.89%
Maint CapEx / Avg PPE
45.5%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
16.0K
Shares Outstanding
83.99M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Marc Fielmann | Chairman of the Mgmt Board, Chief Executive Officer, Head of Strategy, Category Management & Purchasing | 2M | male |
| Bastian Koerber | Chief Sales Officer, Marketing, Expansion, Real Estate & Member of the Management Board | 997.0K | — |
| Katja Gross | CHRO, Head of Digital and IT & Member of Management Board | — | female |
| Nils Scharwaechter | Director of Investor Relations | — | — |
| Peter Lothes | Chief Operating Officer, Head of Manufacturing and Logistics & Member of Management Board | — | male |
| Steffen Baetjer | Chief Financial Officer, Head of Finance, Controlling, Legal and Compliance & Member of Management Board | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for FIE.DE
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
